Regentis Biomaterials LTD

Susan Alpert, a Director of Regentis Biomaterials Ltd., received 24,826 shares of common stock on July 9, 2026.

Pini Ben-Elazar, a Director of Regentis Biomaterials Ltd., reported multiple transactions in common stock on July 9, 2026.

Keith Valentine, a Director of Regentis Biomaterials Ltd., received 24,826 shares of common stock on July 9, 2026.

Jeff Dykan, a Director of Regentis Biomaterials Ltd., reported multiple transactions in common stock on July 9, 2026.

Ehud Geller, Chief Executive Officer and a Director of Regentis Biomaterials Ltd., received 31,250 shares of common stock on July 9, 2026.

Efraim Cohen-Arazi, a Director of Regentis Biomaterials Ltd., received 24,826 shares of common stock on July 9, 2026.

Rosalind Advisors Inc. and its affiliated entities have reported beneficial ownership of 9.9% of Regentis Biomaterials Ltd.'s common shares, primarily through warrants and existing shares.